Involvement of p38 Mitogen-activated Protein Kinase Signaling Pathway in Osteoclastogenesis Mediated by Receptor Activator of NF-κB Ligand (RANKL)
Top Cited Papers
Open Access
- 1 October 2000
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (40), 31155-31161
- https://doi.org/10.1074/jbc.m001229200
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- p62 Functions as a p38 MAP Kinase RegulatorBiochemical and Biophysical Research Communications, 2000
- Pyridinylimidazole Compound SB 203580 Inhibits the Activity but Not the Activation of p38 Mitogen-Activated Protein KinaseBiochemical and Biophysical Research Communications, 1999
- IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisJournal of Clinical Investigation, 1999
- Activation of NF-κB by RANK Requires Tumor Necrosis Factor Receptor-associated Factor (TRAF) 6 and NF-κB-inducing KinasePublished by Elsevier ,1999
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Purification and Identification of a Major Activator for p38 from Osmotically Shocked CellsJournal of Biological Chemistry, 1996
- Characterization of the Bone Morphogenetic Protein-2 as a Neurotrophic FactorPublished by Elsevier ,1996
- MAPKs: new JNK expands the groupTrends in Biochemical Sciences, 1994
- Raf meets Ras: completing the framework of a signal transduction pathwayTrends in Biochemical Sciences, 1994
- The MAP kinase cascade is essential for diverse signal transduction pathwaysTrends in Biochemical Sciences, 1993